A new research paper was published in Volume 16 of Oncotarget on June 25, 2025, titled "Hypoxia induced lipid droplet ...

When the COVID-19 pandemic swept across the world in 2020, the mRNA vaccines came to the rescue of many people—but in the ...

Lipid bilayers in mammalian membranes can have a more asymmetric composition than previously thought, new research shows. This lipid abundance asymmetry is enabled by the unique properties of ...

An approval for the first drug for a rare lipid storage disease, some FDA workers rehired, and other biotech news of the day in the Readout newsletter.

Lipid metabolism plays a vital role in regulating various physiological processes including hormone synthesis, energy production, and fat storage. Alterations in lipid digestion, absorption ...

FDA Approves Mirum Pharmaceuticals Treatment for Lipid-Storage Disease Last Updated: Feb. 21, 2025 at 5:49 p.m. ET First Published: Feb. 21, 2025 at 1:04 p.m. ET Share ...

FDA Approves First Drug for Rare Lipid Storage Disorder — Chenodiol has long been used off-label for cerebrotendinous xanthomatosis by Nicole Lou , Senior Staff Writer, MedPage Today February 21 ...

The Food and Drug Administration approved Mirum Pharmaceuticals' Ctexli to treat Cerebrotendinous Xanthoma, a very rare lipid-storage disease. The approval makes Ctexli, or chenodiol, the first ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. Today, we learn that the Trump administration is ...